Skip to main content
SpringerLink
Log in

Risk Factors for Bile Duct Injury After Percutaneous Thermal Ablation of Malignant Liver Tumors: A Retrospective Case–Control Study

  • Original Article
  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

Abstract

Background

Bile duct injury after ablation of malignant liver tumors (MLTs) was not unusual and should be avoided. However, few studies have focused on evaluating the risk factors for intrahepatic bile duct injury.

Aim

To evaluate the risk factors for intrahepatic bile duct injury after ablation of MLTs and to evaluate the minimum safe distance for ablating tumors abutting bile ducts.

Methods

Sixty-five patients with intrahepatic bile duct injury after ablation of MLTs, and 65 controls were recruited. Risk factors for intrahepatic bile duct injury were analyzed. Tumor location was recorded as ≤5 mm (group A), 5–10 mm (group B), and >10 mm (group C) from the right/left main duct or segmental bile duct.

Results

Ascites history (P < 0.001), TACE treatment history (P = 0.025), intrahepatic bile duct dilatation before ablation (P < 0.001), and tumor location (P = 0.000) were identified as significant risk factors for intrahepatic bile duct injury. Significant differences in the risk of intrahepatic bile duct injury were found between groups B and C (P = 0.000), but not between groups A and B (P = 0.751). Ascites history (P = 0.002) and tumor location (P < 0.001) were independent predictors with the OR (95 % confidence interval) of 39.31(3.95–391.69) and 16.56 (5.87–46.71), respectively.

Conclusions

Bile duct injury after ablation of MLTs was the result of local treatment-related factors combined with the patients’ general condition. The minimum safe distance for ablation of tumor abutting a bile duct was 10 mm.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Fonseca AZ, Santin S, Gomes LG, Waisberg J, Ribeiro MA Jr. Complications of radiofrequency ablation of hepatic tumors: frequency and risk factors. World J Hepatol. 2014;6:107–113.

    Article  PubMed  PubMed Central  Google Scholar 

  2. Forner A, Llovet JM, Bruix J. Hepatocellular carcinoma. Lancet. 2012;379:1245–1255.

    Article  PubMed  Google Scholar 

  3. McGrane S, McSweeney SE, Maher MM. Which patients will benefit from percutaneous radiofrequency ablation of colorectal liver metastases? Critically appraised topic. Abdom Imaging. 2008;33:48–53.

    Article  PubMed  Google Scholar 

  4. Ahmed M, Solbiati L, Brace CL, et al. Image-guided tumor ablation: standardization of terminology and reporting criteria—a 10-year update. Radiology. 2014;273:241–260.

    Article  PubMed  PubMed Central  Google Scholar 

  5. Sakamoto I, Iwanaga S, Nagaoki K, et al. Intrahepatic biloma formation (bile duct necrosis) after transcatheter arterial chemoembolization. Am J Roentgenol (AJR). 2003;181:79–87.

    Article  Google Scholar 

  6. Kim SH, Lim HK, Choi D, et al. Changes in bile ducts after radiofrequency ablation of hepatocellular carcinoma: frequency and clinical significance. Am J Roentgenol (AJR). 2004;183:1611–1617.

    Article  Google Scholar 

  7. Chang IS, Rhim H, Kim SH, et al. Biloma formation after radiofrequency ablation of hepatocellular carcinoma: incidence, imaging features, and clinical significance. Am J Roentgenol (AJR). 2010;195:1131–1136.

    Article  Google Scholar 

  8. de Baère T, Risse O, Kuoch V, et al. Adverse events during radiofrequency treatment of 582 hepatic tumors. Am J Roentgenol (AJR). 2003;181:695–700.

    Article  Google Scholar 

  9. Rhim H, Yoon KH, Lee JM, et al. Major complications after radio-frequency thermal ablation of hepatic tumors: spectrum of imaging findings. Radiographics. 2003;23:123–134.

    Article  PubMed  Google Scholar 

  10. Mulier S, Mulier P, Ni Y, et al. Complications of radiofrequency coagulation of liver tumours. Br J Surg. 2002;89:1206–1222.

    Article  CAS  PubMed  Google Scholar 

  11. Livraghi T, Solbiati L, Meloni MF, et al. Treatment of focal liver tumors with percutaneous radio-frequency ablation: complications encountered in a multicenter study. Radiology. 2003;226:441–451.

    Article  PubMed  Google Scholar 

  12. Curley SA, Marra P, Beaty K, et al. Early and late complications after radiofrequency ablation of malignant liver tumors in 608 patients. Ann Surg. 2004;239:450–458.

    Article  PubMed  PubMed Central  Google Scholar 

  13. Lahat E, Eshkenazy R, Zendel A, et al. Complications after percutaneous ablation of liver tumors: a systematic review. Hepatobiliary Surg Nutr. 2014;3:317–323.

    PubMed  PubMed Central  Google Scholar 

  14. Liang P, Wang Y, Yu X, Dong B. Malignant liver tumors: treatment with percutaneous microwave ablation—complications among cohort of 1136 patients. Radiology. 2009;251:933–940.

    Article  PubMed  Google Scholar 

  15. Shibata T, Yamamoto Y, Yamamoto N, et al. Cholangitis and liver abscess after percutaneous ablation therapy for liver tumors: incidence and risk factors. J Vasc Interv Radiol. 2003;14:1535–1542.

    Article  PubMed  Google Scholar 

  16. Vogl TJ, Straub R, Eichler K, et al. Malignant liver tumors treated with MR imaging-guided laser-induced thermotherapy: experience with complications in 899 patients (2,520 lesions). Radiology. 2002;225:367–377.

    Article  PubMed  Google Scholar 

  17. Dromain C, de Baere T, Elias D, et al. Hepatic tumors treated with percutaneous radio-frequency ablation: CT and MR imaging follow-up. Radiology. 2002;223:255–262.

    Article  PubMed  Google Scholar 

  18. Koda M, Murawaki Y, Hirooka Y, et al. Complications of radiofrequency ablation for hepatocellular carcinoma in a multicenter study: an analysis of 16346 treated nodules in 13283 patients. Hepatol Res. 2012;42:1058–1064.

    Article  PubMed  Google Scholar 

  19. Rhim H, Choi D, Kim YS, Lim HK, Choe BK. Ultrasonography-guided percutaneous radiofrequency ablation of hepatocellular carcinomas: a feasibility scoring system for planning sonography. Eur J Radiol. 2010;75:253–258.

    Article  PubMed  Google Scholar 

  20. Oshima S, Tani N, Takaishi K, et al. Clinical evaluation of the risk factors for liver abscess after TACE or RFA. Gan To Kagaku Ryoho. 2014;41:2113–2115.

    PubMed  Google Scholar 

  21. Kondo Y, Shiina S, Tateishi R, et al. Intrahepatic bile duct dilatation after percutaneous radiofrequency ablation for hepatocellular carcinoma: impact on patient’s prognosis. Liver Int. 2011;31:197–205.

    Article  CAS  PubMed  Google Scholar 

  22. Teratani T, Yoshida H, Shiina S, et al. Radiofrequency ablation for hepatocellular carcinoma in so-called high-risk locations. Hepatology. 2006;43:1101–1108.

    Article  PubMed  Google Scholar 

  23. Bruix J, Sherman M, Llovet JM, et al. Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. J Hepatol. 2001;35:421–430.

    Article  CAS  PubMed  Google Scholar 

  24. Sacks D, McClenny TE, Cardella JF, Lewis CA. Society of Interventional Radiology clinical practice guidelines. J Vasc Interv Radiol. 2003;14:S199–S202.

    Article  PubMed  Google Scholar 

  25. Kuang M, Xie XY, Huang C, et al. Long-term outcome of percutaneous ablation in very early-stage hepatocellular carcinoma. J Gastrointest Surg. 2011;15:2165–2171.

    Article  PubMed  Google Scholar 

  26. Lu MD, Xu HX, Xie XY, et al. Percutaneous microwave and radiofrequency ablation for hepatocellular carcinoma: a retrospective comparative study. J Gastroenterol. 2005;40:1054–1060.

    Article  PubMed  Google Scholar 

  27. Elias D, De Baere T, Smayra T, et al. Percutaneous radiofrequency thermoablation as an alternative to surgery for treatment of liver tumour recurrence after hepatectomy. Br J Surg. 2002;89:752–756.

    Article  CAS  PubMed  Google Scholar 

  28. Elias D, Debaere T, Muttillo I, et al. Intraoperative use of radiofrequency treatment allows an increase in the rate of curative liver resection. J Surg Oncol. 1998;67:190–191.

    Article  CAS  PubMed  Google Scholar 

  29. de Baere T, Elias D, Dromain C, et al. Radiofrequency ablation of 100 hepatic metastases with a mean follow-up of more than 1 year. Am J Roentgenol (AJR). 2000;175:1619–1625.

    Article  Google Scholar 

  30. Pearson AS, Izzo F, Fleming RY, et al. Intraoperative radiofrequency ablation or cryoablation for hepatic malignancies. Am J Surg. 1999;178:592–599.

    Article  CAS  PubMed  Google Scholar 

  31. Dodd GD 3rd, Soulen MC, Kane RA, et al. Minimally invasive treatment of malignant hepatic tumors: at the threshold of a major breakthrough. Radiographics. 2000;20:9–27.

    Article  PubMed  Google Scholar 

  32. Ohnishi T, Yasuda I, Nishigaki Y, et al. Intraductal chilled saline perfusion to prevent bile duct injury during percutaneous radiofrequency ablation for hepatocellular carcinoma. J Gastroenterol Hepatol. 2008;23:e410–e415.

    Article  PubMed  Google Scholar 

  33. Ogawa T, Kawamoto H, Kobayashi Y, et al. Prevention of bile duct injury in radiofrequency ablation for hepatocellular carcinoma—cooling effect by endoscopic nasobiliary drainage tube. Eur J Radiol. 2010;73:385–390.

    Article  PubMed  Google Scholar 

  34. Iida H, Aihara T, Ikuta S, Yamanaka N. Risk of abscess formation after liver tumor radiofrequency ablation: a review of 8 cases with a history of enterobiliary anastomosis. Hepatogastroenterology. 2014;61:1867–1870.

    PubMed  Google Scholar 

  35. Iranpour P, Lall C, Houshyar R, et al. Altered Doppler flow patterns in cirrhosis patients: an overview. Ultrasonography. 2016;35:3–12.

    Article  PubMed  Google Scholar 

  36. Marchal F, Elias D, Rauch P, et al. Prevention of biliary lesions that may occur during radiofrequency ablation of the liver: study on the pig. Ann Surg. 2006;243:82–88.

    Article  PubMed  PubMed Central  Google Scholar 

  37. Chattopadhyay S, Nundy S. Portal biliopathy. World J Gastroenterol. 2012;18:6177–6182.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Interventional Ultrasound, Department of Medical Ultrasonics, The First Affiliated Hospital, Institute for the Study of Diagnostic and Interventional Ultrasound, Sun Yat-Sen University, 58 Zhongshan Road 2, Guangzhou, 510080, People’s Republic of China

    Man-Xia Lin, Jie-Yi Ye, Wen-Shuo Tian, Ming Xu, Bo-Wen Zhuang, Ming-De Lu, Xiao-Yan Xie & Ming Kuang

  2. Department of Hepatobiliary Surgery, The First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, People’s Republic of China

    Ming-De Lu & Ming Kuang

Authors
  1. Man-Xia Lin
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jie-Yi Ye
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Wen-Shuo Tian
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Ming Xu
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Bo-Wen Zhuang
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Ming-De Lu
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Xiao-Yan Xie
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Ming Kuang
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Xiao-Yan Xie.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Lin, MX., Ye, JY., Tian, WS. et al. Risk Factors for Bile Duct Injury After Percutaneous Thermal Ablation of Malignant Liver Tumors: A Retrospective Case–Control Study. Dig Dis Sci 62, 1086–1094 (2017). https://doi.org/10.1007/s10620-016-4312-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10620-016-4312-1

Keywords

Search

Navigation